Pharmacists' perceived knowledge and expertise in selected pediatric topics
Paul J Munzenberger1, Ron L Thomas, Stephanie B Edwin
1Department of Pharmacy Practice, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences.
Summary
Pharmacists feel more confident recommending treatments for common pediatric conditions. Additional pediatric training significantly boosts their perceived knowledge and comfort in advising on child health topics.
Area of Science:
- Pharmacy Practice
- Pediatric Pharmacotherapy
- Healthcare Professional Education
Background:
- Pharmacists play a crucial role in patient care, including pediatric populations.
- Assessing pharmacists' perceived competence in pediatric pharmacotherapy is essential for optimizing child health outcomes.
Purpose of the Study:
- To evaluate pharmacists' self-assessed knowledge and expertise in providing recommendations for pediatric patients.
- To identify factors influencing pharmacists' confidence in pediatric pharmacotherapy.
Main Methods:
- A survey was administered to 400 pharmacists across various practice settings (community, hospital, home care).
- The questionnaire assessed perceived knowledge, expertise, and comfort levels for 38 pediatric topics.
- Demographic factors of respondents were analyzed for their impact on perceived competence.
Main Results:
- A 24% response rate was achieved, with most respondents practicing in community or hospital settings.
- Pharmacists reported higher confidence in addressing common pediatric conditions compared to less familiar ones.
- Formal pediatric training emerged as the most significant factor enhancing perceived knowledge and expertise.
Conclusions:
- Pharmacists' perceived knowledge and comfort in managing pediatric patients are positively influenced by additional training.
- Experience and practice setting (community-based) also contribute to enhanced competence.
- Targeted educational interventions can improve pharmacists' ability to provide pediatric recommendations.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...